According to a 2024 commentary by the team behind a national training project, the Ministry of Health, through the Pharmacy Council, amended the pharmacy regulations in 2020 to make clinical pharmacy services a core function of pharmacists. The listed duties include therapeutic management, multidisciplinary ward rounds and the detection and reporting of adverse drug reactions (ADRs), meaning harmful reactions to medicines. Three months after the project’s training, only 6 of the 17 hospitals supervised had assigned pharmacists to ward rounds or clinics.
The rules have moved faster than the wards. This article sets out what clinical pharmacy services add, where regional, zonal and national referral hospitals stand, and what is holding the services back.
What this means in Tanzania
Most of the evidence on pharmacist-led ward care comes from outside Tanzania. One review covers studies published between 1985 and April 2005. Two others pool African hospital studies. They show what is possible and where the risks lie. They are not Tanzanian rates, and the Tanzanian Standard Treatment Guidelines and national regulations remain the reference for practice. The Tanzanian figures below come from one training project and one point prevalence survey (a survey of what is prescribed on a single day).
Why hospitals need pharmacists doing clinical work
Patients in referral hospitals often have several conditions and take several medicines, which raises the risk of ADRs, drug interactions and missed doses. Noncommunicable diseases added to that complexity: the WHO Regional Office for Africa estimated that they caused 34% of deaths in Tanzania in 2019.
A systematic review of 78 observational studies from 15 African countries put the median prevalence of adverse drug events during hospital stays at 7.8% among general patients, and at 74.2% in studies of specific patient groups or drug exposures. Among general patients, a median of 43.5% of these events were judged preventable (Nyame et al., 2024).
For what pharmacists can do about it, the best-known synthesis is a 2006 systematic review of 36 controlled studies of inpatient pharmacist services: 10 on ward rounds, 11 on medication reconciliation and 15 on drug-specific services. Adverse drug events, reactions or medication errors fell in 7 of the 12 trials that measured them. Hospital stays shortened in 9 of 17 trials. No intervention worsened clinical outcomes (Kaboli et al., 2006). The stay-length result is mixed, so claims about shorter admissions need local data.
Where Tanzanian hospitals stand
A 2024 commentary in Human Resources for Health describes the main Tanzanian effort so far. From August 2021 to December 2022, Muhimbili University of Health and Allied Sciences (MUHAS) and the Christian Social Services Commission, with support from action medeor e.V. of Germany, trained 104 pharmacists from 26 public regional, zonal and national referral hospitals. Training ran from January to July 2022: three days of lectures and discussion, then seven days of hands-on work on ward rounds and clinics.
Three months after training in each hospital, supervisors visited 17 of the 26 and used a checklist completed with the head of pharmacy and the trained pharmacists.
| Indicator (17 hospitals visited) | Hospitals meeting it |
|---|---|
| Clinical pharmacy services had started | 17 |
| Ward-round timetable available | 10 |
| Pharmacists assigned to ward rounds and clinics | 6 |
| Clinical pharmacy focal person appointed | 6 |
| Pharmacists able to access patient information through the hospital information system | 5 |
| Cases seen on rounds documented | 4 |
| Dedicated clinical pharmacy unit | 1 |
| Pharmacist-only ward round held | 0 |
These counts describe structures, not patient outcomes, and they come from the project team’s own supervision visits rather than an independent evaluation. Nurses and doctors in the visited hospitals told supervisors that pharmacists needed to be involved in rounds and clinics.
Four places to start
Ward rounds
On rounds, pharmacists can check dosing, particularly in kidney or liver impairment, and catch prescribing errors before a dose reaches the patient. Where pharmacist numbers are limited, hospitals could begin with high-risk units such as intensive care, nephrology, oncology and paediatrics, and record interventions per 100 admissions and the share that prescribers accept. That is a practical suggestion, not an official requirement.
Antimicrobial stewardship
Antimicrobial resistance (AMR) is a heavy burden in the region. A global analysis estimated 1.27 million deaths attributable to bacterial AMR in 2019, with the highest regional rate in western sub-Saharan Africa at 27.3 per 100,000 population (Antimicrobial Resistance Collaborators, 2022). That is a regional estimate, not a Tanzanian rate.
The second National Action Plan on AMR covers 2023 to 2028. The plan document, dated November 2022, reports that 16 hospitals had been enrolled in antimicrobial stewardship programmes, and that performance against ten core indicators in tertiary and regional referral hospitals ranged from 40% to 84%.
Prescribing data show why stewardship needs laboratory support. In a point prevalence survey at Benjamin Mkapa Zonal Referral Hospital in Dodoma, 30.07% of 286 inpatient prescriptions included an antibiotic. Of those 86 prescriptions, 77.91% (67) followed the Standard Treatment Guidelines, which the authors called suboptimal, and 66.28% were empirical, with no culture or susceptibility test requested (Zimbwe et al., 2024).
A systematic review of pharmacist-led stewardship in sub-Saharan African hospitals found improved guideline adherence and less inappropriate prescribing, but limited by gaps in laboratory and technological support, stewardship time, documentation, guidelines and policies (Otieno et al., 2022). Pharmacy staffing and culture services therefore have to grow together.
Mfamasia has covered the counter-level side of AMR and the seventh edition of the Standard Treatment Guidelines and National Essential Medicines List.
Medicines supply
Hospitals could divide the work. Clinical pharmacists would give clinical input to procurement decisions through the Medicines and Therapeutics Committee, covering therapeutic priorities, appropriate use and utilisation review. Supply-chain pharmacists would lead quantification, forecasting and inventory management with the Medical Stores Department (MSD). This is a proposal for discussion. It keeps clinical pharmacists on the wards, but it has not been tested in a Tanzanian study.
Pharmacovigilance
Pharmacovigilance is the monitoring of medicine safety. A structured reporting programme introduced in seven tertiary hospitals raised the national reporting ratio from 2 reports per million inhabitants in 2018 to 85 per million in 2019. Across the 18 months before and after the programme, reports in Dar es Salaam hospitals rose from 20 to 11,637, in Kilimanjaro from 49 to 316 and in Mbeya from 17 to 77 (Mwamwitwa et al., 2022). The study followed one group before and after, so other changes may have contributed, and counts do not show report quality. The commentary above lists detection and reporting of ADRs among the 2020 regulatory duties.
For the practical steps, see Mfamasia’s article on why adverse drug reactions go unreported in hospital pharmacies.
What is holding services back
The commentary and the baseline survey it draws on name these obstacles:
- Too few pharmacists and intern pharmacists, with other hospital pharmaceutical duties competing for their time.
- Limited skills among pharmacists who did not attend the training, and limited confidence, negative attitudes and poor communication reported at baseline.
- No pharmacist access to patient information through the hospital information system in most visited hospitals, and no space in patient files for pharmacist notes.
- No clinical pharmacy guidelines or standard operating procedures, and no on-the-job training or motivation scheme.
- An unclear career route. MUHAS added clinical pharmacy to its Bachelor of Pharmacy curriculum in 2008 and began a Master of Pharmacy in Hospital and Clinical Pharmacy five years later, but enrolment is low. The authors link this to the lack of remuneration and of recognition as specialists in the scheme of service.
There are also supports to build on. The baseline survey found that hospital administrations were ready to back clinical pharmacy, that nurses and doctors accepted it and that the Pharmacy Act and regulations recognise it.
What the project authors recommend
Because hospital pharmacists carry other duties, the authors say their engagement in clinical pharmacy should be planned and coordinated. They ask the ministries responsible for health and for higher education to treat clinical pharmacy as a core pharmacist function and to reduce the barriers above. The evidence cited here describes whether services exist. Whether they reduce errors, hospital stays or costs in Tanzanian hospitals still needs local studies.
